(Dublin, Ireland) HealthBeacon Ltd., a privately held and innovative connected
medicine company, announced today that Chief Executive Officer Jim Joyce, is scheduled to
present during the JP Morgan Conference at both the Biotech Showcase and the Digital
Medicine Showcase. The conference takes place in San Francisco from January 8th to January
10th .
HealthBeacon’s presentation times and venues:
- Biotech Showcase on Tuesday, January 9th , 2018 at the Hilton San Francisco Union
Square, 333 O’Farrell Street at 1:45pm (PST) – Franciscan A Ballroom Level. - Digital Medicine & Medtech Showcase on Wednesday, January 10th , 2018 at the hotel
Parc 55 San Francisco at 2:15 pm (PST) – 4th Floor Magnin III
About HealthBeacon: The company headquartered in Dublin, Ireland with offices in Boston and
Montreal was established by serial medical technology entrepreneurs, Jim Joyce (CEO) and
Kieran Daly (CTO) to address an opportunity to use digital health technology to target the
medical adherence of high value medications. HealthBeacon’s award winning “smart sharps
solution”, connected via Internet of Things (IoT) technology, addresses medical adherence for
patients on chronic injection therapy in conditions like Diabetes, Multiple Sclerosis, Rheumatoid
Arthritis, Crohn’s Disease, in addition to various respiratory conditions. HealthBeacon has moved
at high velocity from concept to global roll-out in only four years. The solution is already available
and operating in 8 countries, in conjunction with major Pharma companies and is launching into
an additional 11 countries in 2018. HealthBeacon’s application for FDA clearance was submitted in August 2017, with anticipated US commercial availability in Q1 2018.
Follow us on
Twitter: https://twitter.com/healthbeaconinc
LinkedIn: https://ie.linkedin.com/company/healthbeacon
Contacts
Brie Kelly, brie@healthbeacon.com
http://www.healthbeacon.com